A phase III trial of cefiderocol
Latest Information Update: 02 Feb 2024
At a glance
- Drugs Cefiderocol (Primary)
- Indications Gram-negative infections
- Focus Registrational; Therapeutic Use
Most Recent Events
- 02 Feb 2024 New trial record
- 31 Jan 2024 According to a Shinogi media release, the company has received approval from the Hainan Medical Products Administration for the clinical use of cefiderocol, a new siderophore cephalosporin antibiotic, in Boao Lecheng International Medical Tourism Pilot Zone, Hainan, China.
- 31 Jan 2024 According to a Shinogi media release, Ping An-Shionogi is currently conducting this trial in china for the regular approval application of cefiderocol.